The reduction in anabolic components, such as growth hormone (GH) and insulin-like growth factor one (IGF-1), associated with the greater expression of catabolic substances that occurs with aging, compromises muscle homeostasis, thus reflecting a pathogenic pillar for sarcopenia [194,195]. The gene discussed is GH1; the disease is sarcopenia.